Skip to main content
logo
From Bio Co.,Ltd (KOSDAQ:377220)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,685.00
+355.00 (10.66%)
At close: Aug 11, 2026

From Bio Co.,Ltd Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
72,83272,16267,18266,72499,330135,103
Revenue Growth
9.92%7.41%0.69%-32.83%-26.48%-
Gross Profit
42,36841,55137,14545,95569,309102,104
Operating Income
-19,578-18,601-24,271-15,420897.0211,424
Net Income
-23,366-22,457-25,288-11,0763,24111,282
Earnings Per Share
-4124.71-3966.29-4465.00-1956.24570.002303.11
EPS Growth
-----75.25%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,4862,2932,9766,44026,81044,104
Total Debt
34,76735,41126,85018,758485.67492.39
Net Cash (Debt)
-33,280-33,118-23,874-12,31826,32443,611
Net Cash Growth
-----39.64%-
Net Cash Per Share
-5874.79-5849.21-4215.35-2175.534649.218902.73

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-8,233-10,072-14,700-20,845-2,023-1,175
Capital Expenditures
-863.29-1,104-893.42-16,656-13,589-8,781
Free Cash Flow
-9,096-11,176-15,593-37,501-15,613-9,956
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
58.17%57.58%55.29%68.87%69.78%75.58%
Operating Margin
-26.88%-25.78%-36.13%-23.11%0.90%8.46%
Pretax Margin
-29.69%-28.93%-37.05%-23.59%1.52%8.61%
Profit Margin
-32.08%-31.12%-37.64%-16.60%3.26%8.35%
FCF Margin
-12.49%-15.49%-23.21%-56.20%-15.72%-7.37%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----36.5613.68
PS Ratio
0.290.490.781.301.191.14